Optogenetics Actuators And Sensors Market To Reach $630.1 Million By 2030

Optogenetics Actuators and Sensors Market Growth & Trends

The global optogenetics actuators and sensors market size is estimated to reach USD 630.1 million by 2030, registering a CAGR of 1.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Extensive research in the field of neuroscience and ophthalmology is expected to boost the market growth in the coming years. Key players are focusing majorly on research activities to study brain functions in various psychiatric and retinal disease states, which is anticipated to drive the sector.

Government organizations are providing funds to academic research institutions and individual researchers for advancements in the field of optogenetics. Moreover, various initiatives undertaken by international organizations such as WHO and NIH are anticipated to boost the market growth. Various projects and initiatives initiated in the field of neuroscience are also promoting growth prospects.

In addition, ongoing investigations to improve signal sizes and responses and target specificity of subcellular membranes such as axon terminals, cell bodies, and dendrites in neuroscience are expected to support the growth of the segment. Rise in incidence of retinal and brain disorders are ultimately increasing demand for optogenetic actuators and sensors.

Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to drive technological progressions in optogenetics. This, in turn, is anticipated to significantly boost the growth of the optogenetics actuators and sensors market over the forecast period.

 Request a free sample copy or view report summary: Optogenetics Actuators And Sensors Market Report

Optogenetics Actuators and Sensors Market Report Highlights

• Actuators are estimated to account for the largest revenue share owing to their increased usage in investigations related to neuroscience and ophthalmology

• Sensors are anticipated to grow at the fastest rate in the coming years due to technological advancements in optogenetics

• Retinal disorders accounted for the largest revenue share owing to higher usage of optogenetic actuators and sensors in disease-oriented studies. Rise in prevalence of various retinal and psychiatric disorders is also anticipated to boost the segment

• North America dominated the market owing to government support, extensive research, local presence of a substantial number of players, and well-established healthcare framework

• Asia Pacific is expected to exhibit the fastest growth over the forecast period owing to progressive industrialization and favorable government support

• Companies are collaborating with academic institutions and private and public entities to accelerate developments in optogenetics.

Optogenetics Actuators and Sensors Market Segmentation

Grand View Research has segmented the global optogenetics actuators and sensors market based on product, disease, and region:

Optogenetics Actuators & Sensors Product Outlook (Revenue, USD Million, 2018 - 2030)

• Actuators

  • Channelrhodopsin

  • Halorhodopsin

  • Archaerhodopsin

• Sensors

  • Genetically Encoded Calcium Indicators

  • Voltage-sensitive Fluorescent Proteins

  • pH Sensors

Optogenetics Actuators & Sensors Disease Outlook (Revenue, USD Million, 2018 - 2030)

• Retinal Disorders

• Parkinson’s Disease

• Anxiety & Depression

• Autism

• Schizophrenia

• Others

Optogenetics Actuators & Sensors Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Optogenetics Actuators and Sensors Market

• Elliot Scientific Ltd.

• GenSight Biologics

• Thorlabs, Inc.

• Addgene, Inc.

• The Jackson Laboratory

• Bruker

• Noldus Information Technology BV.

• Prizmatix

• Danaher Corporation

• Merck KGaA

• Shanghai Laser & Optics Century Co., Ltd. (SLOC)

• AGTC

• Scientifica (Judges Scientific Plc Company)